Updates

CSRXP: INSULIN ACT MAY PROVIDE SHORT TERM RELIEF FOR SOME PATIENTS BUT WON’T ADDRESS ROOT CAUSE OF OUT-OF-CONTROL DRUG PRICES

Jul 19, 2022

Congress Must Advance Bipartisan, Market-Based Solutions to Hold Big Pharma Read More

ICYMI: USPTO, FDA ANNOUNCE PLAN TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Jul 19, 2022

Joint Effort Aims to Curb Anti-Competitive Tactics Used by Brand Name Drug Read More

CSRXP: BIG PHARMA BRAZENLY INCREASES PRICES ON MORE THAN 100 DRUGS TO START JULY PRICE-GOUGING

Jul 12, 2022

Brand Name Drug Companies Begin Second Round of Biannual Price Hikes While Read More

SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION

Jul 11, 2022

PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t Read More

BIG PHARMA WATCH: ABBVIE UTILIZED LOOPHOLES TO AVOID PAYING BILLIONS IN U.S. TAXES & FURTHER MAXIMIZE PROFITS WHILE HIKING PRICES

Jul 8, 2022

Committee Report Shows How Brand Name Drug Company Further Juiced Profits on Read More

CSRXP APPLAUDS MOMENTUM TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES

Jun 29, 2022

Congress Should Swiftly Advance Solutions to Deliver Relief for Millions of Read More

DOSE OF REALITY: PATENT HEARINGS OFFER OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE PRACTICES

Jun 22, 2022

Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives Read More

SECOND OPINION: PHRMA REDUXES DEBUNKED BLAME GAME RHETORIC IN NEW AD CAMPAIGN

Jun 17, 2022

Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade Read More

THEY SAID IT! ANTITRUST EXPERTS AND OFFICIALS SHINE A LIGHT ON BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK

Jun 16, 2022

Federal Trade Commission Workshop Highlights How Brand Name Drug Companies Read More

BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 20 PERCENT EVERY YEAR FOR 14 YEARS

Jun 9, 2022

Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In Read More

ICYMI: CBO FINDS HOLDING BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE TACTICS WOULD SAVE BILLIONS OF DOLLARS

Jun 8, 2022

Scoring Shows Solutions to Crack Down on Branded Drug Companies’ Read More